首页 | 本学科首页   官方微博 | 高级检索  
     


BRAF V600E Mediates Crizotinib Resistance and Responds to Dabrafenib and Trametinib in a ROS1-Rearranged Non-Small Cell Lung Cancer: A Case Report
Authors:Juan Li  Qifeng Wang  Jun Ge  Yuke Tian  Wenxiu Yao
Affiliation:1. Departments of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China;2. Departments of Thoracic Radiotherapy, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China
Abstract:
Keywords:ROS1 fusion  BRAF V600E  Non-small cell lung cancer  Crizotinib resistance  Dabrafenib and trametinib
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号